Zobrazeno 1 - 5
of 5
pro vyhledávání: '"MacKenzie Zarecki"'
Autor:
Kenji Fujiwara, Hao Jing, Brian Herbst, MacKenzie Zarecki, Annie Wu, Elaine Bigelow, Keyu Li, Neolle Jurcak, Alex B Blair, Michael Wichroski, Jordan Blum, Nathan Cheadle, Jennifer Koenitzer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Externí odkaz:
https://doaj.org/article/1b5b58fe2f39457890d602f409337ca9
Autor:
Kenji Fujiwara, Hao Jing, Brian Herbst, MacKenzie Zarecki, Annie Wu, Elaine Bigelow, Keyu Li, Neolle Jurcak, Alex B Blair, Michael Wichroski, Jordan Blum, Nathan Cheadle, Jennifer Koenitzer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Externí odkaz:
https://doaj.org/article/ad7572f4311c4f74a5317aac743bdf3d
Autor:
Kenji Fujiwara, Hao Jing, Brian Herbst, MacKenzie Zarecki, Annie Wu, Elaine Bigelow, Keyu Li, Neolle Jurcak, Alex B Blair, Michael Wichroski, Jordan Blum, Nathan Cheadle, Jennifer Koenitzer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Radiation therapy (RT) has the potential to enhance the efficacy of immunotherapy, such as checkpoint inhibitors, which has dramatically altered the landscape of treatments for many cancers, but not yet for pancreatic ductal adenocarcinoma
Externí odkaz:
https://doaj.org/article/468e45316311472f8fc837a650b30475
Autor:
Nathan L. Cheadle, Michael Wichroski, Kenji Fujiwara, Brian Herbst, Keyu Li, Lei Zheng, MacKenzie Zarecki, Hao Jing, Stephen Muth, Neolle Jurcak, Elaine Bigelow, May Tun Saung, Jordan Blum, Alex B. Blair, Jennifer Koenitzer, Ding Ding, Linda Chen, Annie A. Wu
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
BackgroundRadiation therapy (RT) has the potential to enhance the efficacy of immunotherapy, such as checkpoint inhibitors, which has dramatically altered the landscape of treatments for many cancers, but not yet for pancreatic ductal adenocarcinoma
Autor:
Stephen Muth, MacKenzie Zarecki, Noelle R. Jurcak, Elizabeth M. Jaffee, Noah Rozich, Lei Zheng, Julie M. Bailis, Fei Lee, Sabine Stienen
Publikováno v:
Cancer Research. 79:1561-1561
Bispecific T cell engager (BiTE®) antibody constructs are designed to redirect T cells to induce lysis of tumor cells through simultaneous binding to CD3 on T cells and to a tumor associated antigen. BiTE® antibody constructs have previously been s